Abstract Background Osteosarcoma (OS) is the most common primary malignant bone tumor occurring in children and young adults. Drug-resistant osteosarcoma often results in chemotherapy failure. Therefore. new treatments aimed at novel therapeutic targets are urgently needed for the treatment of drug-resistant osteosarcoma. https://www.markymarkscott.com/product-category/5vv-max/